ArticleFrontiers in pharmacology2024

Catalpol reduced LPS induced BV2 immunoreactivity through NF-κB/NLRP3 pathways: an

Yong She et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.